FHIP1A
gene geneOn this page
Also known as FLJ43373FHIP-L
Summary
FHIP1A (FHF complex subunit HOOK interacting protein 1A, HGNC:34237) is a protein-coding gene on chromosome 4q31.3, encoding FHF complex subunit HOOK-interacting protein 1A (Q05DH4). Probable component of the FTS/Hook/FHIP complex (FHF complex).
Involved in protein localization to perinuclear region of cytoplasm.
Source: NCBI Gene 729830 — RefSeq curated summary.
At a glance
- GWAS associations: 7
- Clinical variants (ClinVar): 189 total
- MANE Select transcript:
NM_001109977
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34237 |
| Approved symbol | FHIP1A |
| Name | FHF complex subunit HOOK interacting protein 1A |
| Location | 4q31.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ43373, FHIP-L |
| Ensembl gene | ENSG00000164142 |
| Ensembl biotype | protein_coding |
| Entrez | 729830 |
Gene structure
Transcript identifiers
Ensembl transcripts: 16 — 13 protein_coding, 3 protein_coding_CDS_not_defined
ENST00000435205, ENST00000503146, ENST00000505231, ENST00000508198, ENST00000508664, ENST00000511501, ENST00000512597, ENST00000513086, ENST00000513962, ENST00000883036, ENST00000883037, ENST00000883038, ENST00000883039, ENST00000883040, ENST00000923453, ENST00000923454
RefSeq mRNA: 2 — MANE Select: NM_001109977
NM_001109977, NM_001348694
CCDS: CCDS47146
Canonical transcript exons
ENST00000435205 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001403367 | 151454701 | 151454808 |
| ENSE00001409305 | 151482524 | 151482648 |
| ENSE00003756037 | 151662501 | 151670503 |
| ENSE00003843304 | 151409176 | 151409465 |
| ENSE00003889911 | 151638677 | 151638756 |
| ENSE00003891067 | 151649459 | 151650592 |
| ENSE00003891100 | 151577450 | 151578076 |
| ENSE00003891398 | 151588840 | 151588926 |
| ENSE00003892600 | 151646558 | 151646748 |
| ENSE00003892703 | 151656232 | 151656410 |
| ENSE00003892881 | 151566138 | 151566364 |
| ENSE00003893316 | 151629702 | 151629869 |
| ENSE00003894138 | 151586641 | 151586799 |
| ENSE00003895936 | 151656760 | 151656898 |
Expression profiles
Bgee: expression breadth ubiquitous, 216 present calls, max score 96.47.
FANTOM5 (CAGE): breadth broad, TPM avg 5.1179 / max 280.2040, expressed in 879 samples.
FANTOM5 promoters (6 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 50011 | 3.8496 | 802 |
| 50012 | 0.5211 | 292 |
| 50013 | 0.4485 | 213 |
| 50010 | 0.1196 | 49 |
| 50014 | 0.0947 | 31 |
| 50015 | 0.0843 | 22 |
Top tissues by expression
250 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| buccal mucosa cell | CL:0002336 | 96.47 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 90.82 | gold quality |
| quadriceps femoris | UBERON:0001377 | 90.23 | gold quality |
| tibialis anterior | UBERON:0001385 | 90.16 | gold quality |
| vastus lateralis | UBERON:0001379 | 89.82 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 89.70 | gold quality |
| deltoid | UBERON:0001476 | 89.65 | gold quality |
| upper arm skin | UBERON:0004263 | 89.51 | gold quality |
| cartilage tissue | UBERON:0002418 | 89.02 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 89.02 | gold quality |
| oviduct epithelium | UBERON:0004804 | 87.15 | gold quality |
| gingival epithelium | UBERON:0001949 | 87.07 | gold quality |
| gastrocnemius | UBERON:0001388 | 86.84 | gold quality |
| muscle of leg | UBERON:0001383 | 86.76 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.69 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 86.16 | gold quality |
| muscle tissue | UBERON:0002385 | 85.75 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 85.55 | gold quality |
| gingiva | UBERON:0001828 | 84.96 | gold quality |
| biceps brachii | UBERON:0001507 | 84.73 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 83.87 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 83.80 | gold quality |
| oocyte | CL:0000023 | 83.51 | gold quality |
| amniotic fluid | UBERON:0000173 | 81.69 | gold quality |
| ileal mucosa | UBERON:0000331 | 81.68 | gold quality |
| skin of abdomen | UBERON:0001416 | 80.39 | gold quality |
| zone of skin | UBERON:0000014 | 80.36 | gold quality |
| skin of leg | UBERON:0001511 | 80.26 | gold quality |
| secondary oocyte | CL:0000655 | 79.05 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 78.42 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.86 |
| E-ENAD-17 | no | 130.32 |
| E-MTAB-6142 | no | 35.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
115 targeting FHIP1A, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-12118 | 100.00 | 65.88 | 1270 |
| HSA-MIR-4668-3P | 100.00 | 68.74 | 2635 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-6891-5P | 99.98 | 66.53 | 1372 |
| HSA-MIR-19A-3P | 99.98 | 75.33 | 2762 |
| HSA-MIR-19B-3P | 99.98 | 75.44 | 2754 |
| HSA-MIR-3173-3P | 99.98 | 66.49 | 1217 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-8082 | 99.95 | 67.27 | 1170 |
| HSA-MIR-559 | 99.95 | 72.28 | 3609 |
| HSA-MIR-548AB | 99.95 | 71.31 | 3488 |
| HSA-MIR-548A-5P | 99.94 | 71.27 | 3482 |
Literature-anchored findings (GeneRIF, showing 1)
- this report implicates a novel recessive germline mutation in FAM160A1 with familial NKTL. (PMID:30420729)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fhip1aa | ENSDARG00000061021 |
| danio_rerio | fhip1ab | ENSDARG00000102585 |
| mus_musculus | Fhip1a | ENSMUSG00000051000 |
| rattus_norvegicus | Fhip1a | ENSRNOG00000048256 |
| drosophila_melanogaster | CG3558 | FBGN0025681 |
| caenorhabditis_elegans | WBGENE00015485 |
Paralogs (3): FHIP1B (ENSG00000051009), FHIP2A (ENSG00000151553), FHIP2B (ENSG00000158863)
Protein
Protein identifiers
FHF complex subunit HOOK-interacting protein 1A — Q05DH4 (reviewed: Q05DH4)
Alternative names: FTS- and Hook-interacting protein like
All UniProt accessions (5): D6RAG2, D6RBF5, D6RDL4, D6RF38, Q05DH4
UniProt curated annotations — full annotation on UniProt →
Function. Probable component of the FTS/Hook/FHIP complex (FHF complex). FHF complex promotes the distribution of AP-4 complex to the perinuclear area of the cell.
Subunit / interactions. May be a component of the FTS/Hook/FHIP complex (FHF complex), composed of AKTIP/FTS, FHIP1B, and one or more members of the Hook family of proteins HOOK1, HOOK2, and HOOK3. May interact directly with AKTIP/FTS.
Similarity. Belongs to the FHIP family.
RefSeq proteins (2): NP_001103447, NP_001335623 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR019384 | FHIP | Family |
| IPR045668 | FHIP_KELAA_motif | Conserved_site |
| IPR045669 | FHIP_C | Domain |
Pfam: PF10257, PF19311, PF19314
UniProt features (9 total): compositionally biased region 4, region of interest 3, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q05DH4-F1 | 65.15 | 0.31 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 101 (showing top):
GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, WATANABE_ULCERATIVE_COLITIS_WITH_CANCER_UP, RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GAVIN_FOXP3_TARGETS_CLUSTER_P3, RAY_TUMORIGENESIS_BY_ERBB2_CDC25A_DN, GOBP_INTRACELLULAR_TRANSPORT, GOCC_FHF_COMPLEX, ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_DN, GOBP_MICROTUBULE_BASED_TRANSPORT, GSE14699_NAIVE_VS_ACT_CD8_TCELL_UP, UBN1_TARGET_GENES, ZNF423_TARGET_GENES, ZNF561_TARGET_GENES
GO Biological Process (1): protein localization to perinuclear region of cytoplasm (GO:1905719)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular protein localization | 1 |
| binding | 1 |
Protein interactions and networks
STRING
670 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FHIP1A | AKTIP | Q9H8T0 | 606 |
| FHIP1A | LZTS2 | Q9BRK4 | 596 |
| FHIP1A | HOOK3 | Q86VS8 | 539 |
| FHIP1A | FHIP2A | Q5W0V3 | 511 |
| FHIP1A | SIPA1L1 | O43166 | 508 |
| FHIP1A | GULP1 | Q9UBP9 | 499 |
| FHIP1A | GPR26 | Q8NDV2 | 497 |
| FHIP1A | HOOK1 | Q9UJC3 | 477 |
| FHIP1A | BRINP1 | O60477 | 457 |
| FHIP1A | HOOK2 | Q96ED9 | 443 |
| FHIP1A | WDR35 | Q9P2L0 | 441 |
| FHIP1A | LRIG3 | Q6UXM1 | 436 |
| FHIP1A | MYO6 | Q9UM54 | 435 |
| FHIP1A | URI1 | O94763 | 432 |
| FHIP1A | ATG9A | Q7Z3C6 | 405 |
| FHIP1A | SPATA31F1 | Q6ZU69 | 405 |
IntAct
17 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| HOOK3 | FHIP1A | psi-mi:“MI:0914”(association) | 0.710 |
| FHIP1A | AKTIP | psi-mi:“MI:0915”(physical association) | 0.640 |
| AKTIP | FHIP1A | psi-mi:“MI:0915”(physical association) | 0.640 |
| FHIP1A | FHIP1A | psi-mi:“MI:0915”(physical association) | 0.520 |
| AP4M1 | FHIP1A | psi-mi:“MI:0915”(physical association) | 0.520 |
| ESR1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| AKTIP | FHIP1A | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP1A | HOOK2 | psi-mi:“MI:0914”(association) | 0.350 |
| AKTIP | PGGT1B | psi-mi:“MI:0914”(association) | 0.350 |
| AKTIP | ALDH1A2 | psi-mi:“MI:0914”(association) | 0.350 |
| HOOK3 | ETHE1 | psi-mi:“MI:0914”(association) | 0.350 |
| FHIP1A | ILVBL | psi-mi:“MI:2364”(proximity) | 0.270 |
| MYO6 | GIPC1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| GIPC1 | STRN | psi-mi:“MI:2364”(proximity) | 0.270 |
BioGRID (43): FAM160A1 (Affinity Capture-MS), FAM160A1 (Affinity Capture-MS), FAM160A1 (Affinity Capture-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Affinity Capture-RNA), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Affinity Capture-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS), FAM160A1 (Proximity Label-MS)
ESM2 similar proteins: A0A0G2JV04, B0V207, D3Z8X7, D3ZFJ3, D3ZND0, F1LM81, G9CGD6, O00499, O08539, O08839, O12940, O60308, O60784, O75674, O88746, P42567, P55194, Q05DH4, Q0GNC1, Q0IHV1, Q27J81, Q3B7M3, Q3UN70, Q4KLN4, Q505K2, Q5FVK6, Q5T0F9, Q5U3K5, Q66HA5, Q68EF0, Q6P1N0, Q6P5E6, Q6P9Q4, Q6P9Q6, Q80V31, Q80V94, Q8BMI3, Q8BRN9, Q8K1A6, Q8R0H9
Diamond homologs: A7S6A1, A7YY62, B0X755, B3MLI0, B3NAN9, B4G8N3, B4JQY3, B4KJS5, B4LQW4, B4MTY2, B4NXB9, B5DI68, Q05DH4, Q17AI4, Q3U2I3, Q505K2, Q5R8V2, Q66H54, Q7PZ36, Q8N612, Q9VQK0, A8XW52, B0V207, Q11187, A8P7J8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
189 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 168 |
| Likely benign | 12 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
3539 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:151409464:AGGTA:A | donor_loss | 1.0000 |
| 4:151415712:T:A | acceptor_gain | 1.0000 |
| 4:151578072:GTCCA:G | donor_gain | 1.0000 |
| 4:151578073:TCCA:T | donor_gain | 1.0000 |
| 4:151578073:TCCAG:T | donor_loss | 1.0000 |
| 4:151578076:AG:A | donor_loss | 1.0000 |
| 4:151578077:G:GG | donor_gain | 1.0000 |
| 4:151578078:TAAG:T | donor_loss | 1.0000 |
| 4:151586863:GAT:G | donor_gain | 1.0000 |
| 4:151629694:T:TA | acceptor_gain | 1.0000 |
| 4:151629696:TCCTA:T | acceptor_loss | 1.0000 |
| 4:151629697:CCTA:C | acceptor_loss | 1.0000 |
| 4:151629698:CTA:C | acceptor_loss | 1.0000 |
| 4:151629699:TA:T | acceptor_loss | 1.0000 |
| 4:151629700:A:AG | acceptor_gain | 1.0000 |
| 4:151629700:AGGT:A | acceptor_gain | 1.0000 |
| 4:151629701:G:GG | acceptor_gain | 1.0000 |
| 4:151629701:GGT:G | acceptor_gain | 1.0000 |
| 4:151629701:GGTG:G | acceptor_gain | 1.0000 |
| 4:151629865:TTCGG:T | donor_loss | 1.0000 |
| 4:151629866:TCGGG:T | donor_loss | 1.0000 |
| 4:151629867:CGGG:C | donor_loss | 1.0000 |
| 4:151629868:GG:G | donor_gain | 1.0000 |
| 4:151629868:GGGTA:G | donor_loss | 1.0000 |
| 4:151629869:GG:G | donor_gain | 1.0000 |
| 4:151629869:GGTA:G | donor_loss | 1.0000 |
| 4:151629870:G:GC | donor_loss | 1.0000 |
| 4:151629870:G:GG | donor_gain | 1.0000 |
| 4:151629871:T:G | donor_loss | 1.0000 |
| 4:151646708:G:GT | donor_gain | 1.0000 |
AlphaMissense
6874 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:151588889:G:A | G314E | 1.000 |
| 4:151588891:T:C | F315L | 1.000 |
| 4:151588892:T:C | F315S | 1.000 |
| 4:151588893:T:A | F315L | 1.000 |
| 4:151588893:T:G | F315L | 1.000 |
| 4:151588904:T:A | V319D | 1.000 |
| 4:151629739:T:C | L339P | 1.000 |
| 4:151629841:T:C | L373P | 1.000 |
| 4:151577654:T:A | W104R | 0.999 |
| 4:151577654:T:C | W104R | 0.999 |
| 4:151577946:T:C | L201P | 0.999 |
| 4:151577988:C:A | A215D | 0.999 |
| 4:151577991:G:C | R216P | 0.999 |
| 4:151578071:T:C | C243R | 0.999 |
| 4:151586645:T:A | L246H | 0.999 |
| 4:151586645:T:C | L246P | 0.999 |
| 4:151586653:G:A | G249R | 0.999 |
| 4:151586653:G:C | G249R | 0.999 |
| 4:151586653:G:T | G249W | 0.999 |
| 4:151586654:G:A | G249E | 0.999 |
| 4:151586657:T:A | L250H | 0.999 |
| 4:151586657:T:C | L250P | 0.999 |
| 4:151586659:A:C | S251R | 0.999 |
| 4:151586661:T:A | S251R | 0.999 |
| 4:151586661:T:G | S251R | 0.999 |
| 4:151586663:G:A | G252D | 0.999 |
| 4:151586666:T:C | L253P | 0.999 |
| 4:151586668:T:G | Y254D | 0.999 |
| 4:151586678:T:C | L257P | 0.999 |
| 4:151586774:T:C | L289P | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000011589 (4:151474321 A>G), RS10000281 (4:151599338 C>G), RS1000039283 (4:151541486 A>G), RS1000040417 (4:151500276 G>C), RS1000064233 (4:151427882 A>G,T), RS1000074548 (4:151522750 A>C), RS1000075014 (4:151658466 G>A), RS1000089876 (4:151448932 A>G), RS1000090944 (4:151568144 A>G,T), RS1000117731 (4:151513451 T>A), RS1000125462 (4:151632721 A>G), RS1000130561 (4:151543675 T>C), RS1000143946 (4:151459469 A>G), RS1000147660 (4:151523044 C>A), RS1000155853 (4:151500826 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
7 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004603_224 | Platelet count | 2.000000e-12 |
| GCST004607_229 | Plateletcrit | 4.000000e-10 |
| GCST010837_3 | Intracerebral hemorrhage | 6.000000e-06 |
| GCST90000025_291 | Appendicular lean mass | 2.000000e-22 |
| GCST90002400_673 | Plateletcrit | 1.000000e-26 |
| GCST90002402_753 | Platelet count | 3.000000e-27 |
| GCST90002407_449 | White blood cell count | 4.000000e-13 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0007985 | platelet crit |
| EFO:0004980 | appendicular lean mass |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
28 total (human), top 28 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, increases abundance, increases expression | 2 |
| Oxygen | decreases reaction, increases expression | 2 |
| Particulate Matter | decreases expression, increases abundance | 2 |
| aristolochic acid I | decreases expression | 1 |
| 1-cyclopropyl-4-(4-((5-methyl-3-(3-(4-(trifluoromethoxy)phenyl)-1,2,4-oxadiazol-5-yl)-1H-pyrazol-1-yl)methyl)pyridin-2-yl)piperazine | decreases reaction, increases expression | 1 |
| fluorene-9-bisphenol | increases expression | 1 |
| sotorasib | affects cotreatment, decreases expression | 1 |
| dicrotophos | increases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | increases abundance, increases expression | 1 |
| butyraldehyde | increases expression | 1 |
| potassium chromate(VI) | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| chromium hexavalent ion | decreases expression | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| trametinib | affects cotreatment, decreases expression | 1 |
| NVP-BKM120 | affects cotreatment, decreases expression | 1 |
| Sunitinib | increases expression | 1 |
| Air Pollutants | increases abundance, decreases expression | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Cisplatin | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Nickel | increases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Urethane | increases expression | 1 |
| Valproic Acid | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): intracerebral hemorrhage